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Foreword 
Continuing change in key factors important to industrial 
plant location requires periodic review of established loca-
tion patterns. This analysis focuses on factors which should 
make Atlanta an attractive location for new antibiotics plants. 
Decentralization of the industry appears to be a logical 
move to take advantage of a combination of significant factors 
affecting antibiotics manufacture. The opportunity to serve a 
regional market profitably from Atlanta is one such factor. 
More important, however, are the opportunities and economies 
to be found in the unusual combination of attractions which 
exist in Atlanta. 
This report is the fourth in the series of special techni-
cal reports on manufacturing opportunities in Atlanta. Comments, 
questions and confidential requests for additional information 
are invited. 
Kenneth C. Wagner, Head 
Industrial Development Branch 
GEORGIA INSTITUTE OF TECHNOLOGY 
Summary 
The tonnage of antibiotics sold increased almost 170 per cent between 
1951 and 1960. In 1958 manufacturers' sales were $431 million nationally and 
should reach $750 million in 1968. 
There will definitely be a considerable need for additional facilities 
at the rate the industry is expanding. Although there has been no tendency 
toward decentralization as yet, there would be a number of advantages to 
putting a plant in the Atlanta area: 
1. Significantly higher production could be expected per dollar of 
wages paid, providing a substantial increase in net operating profits. 
2. An excellent water supply is available from the Chattahoochee River, 
where the water temperature is sufficiently low to be used for cooling 
purposes in the production process. 
3. Better waste disposal facilities are available than in most other 
sections of the country. 
4. The plant would be located at a major transportation-distribution 
point. 
Since Atlanta is a research center, a sizable number of scientists, 
engineers, and technicians are available at the educational, industrial 
and governmental research facilities in the area. 
These assets should place an Atlanta area plant at a distinct competi-
tive advantage over plants in other sections of the country. 
A "bonus" exists in the size of the local and regional market. Since 
antibiotics manufacturing has not been market oriented, plants have not been 
constructed to serve regional markets. However, a market near a plant is 
always an asset and more drugs are wholesaled in Atlanta ($233 million in 
1958) than in any one of 41 states. New York, Chicago, and Los Angeles are 
the only cities with higher sales. In view of the exceptionally rapid 
expansion of the consumption of antibiotics, it is easy to imagine the South 
consuming the entire output of a new plant. 
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INTRODUCTION 
This report is intended primarily for those companies already manufac-
turing antibiotics and is designed to show them the opportunities which exist 
to make profits by means of locating new manufacturing plants in the Atlanta 
area. 
The antibiotics industry has been characterized by very rapid expansion 
and many new plants will be needed to supply the future demand. This report 
points out the advantages Atlanta offers as a site for the new plants which 
will be needed to meet expanding markets. 
For those readers not familiar with the industry, a brief description 
of the background for this report follows. 
The Production Process  
Most antibiotics are produced basically through the controlled growth 
and multiplication of selected strains of microorganisms. The particular 
strains of microorganism selected for the production of antibiotics are 
those which will inhibit the growth of or destroy other microorganisms 
which cause diseases in humans and animals. Commercial production of most 
antibiotics is accomplished through the controlled growth of certain micro-
organisms using a fermentation process. 
There are certain primary considerations involved in selecting a 
location for an antibiotics plant. Each is discussed briefly below. 
Availability of a Large Water Supply 
Water is used both in the processing broth and for cooling purposes 
during the fermentation process. It has been estimated that enough water 
is used daily by one antibiotics plant to supply 100,000 people. 
Waste Disposal Facilities  
The thousands of gallons of broth from which the antibiotics are re-
covered create a waste disposal problem. The broth contains mycelia, 
remnants of the nutrients used, and small quantities of the antibiotics. 
The volume of waste broth is too great for most sewage systems. It is there-
fore desirable to locate a plant near an ocean or a very large river where 
the pumping of the waste into these waters is allowable. Otherwise, a large 
area of land is required for burial of the waste matter. 
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Availability of Land  
If disposal of waste into a large body of water is impossible, the 
burial method of disposal must be used. This method requires a large area 
of land adjacent to the plant site. Therefore, a plant which utilizes this 
method of disposal needs to be located in an area where sufficient land is 
available at a reasonably low price. 
Cost of Labor  
Price competition among the major producers, plus the requirement of 
increased expenditures for sales promotion and research as a per cent of net 
sales, 	have caused the major manufacturers in the industry to become more 
concerned with the controllable costs of production -- particularly labor 
costs. Labor rates vary significantly in different sections of the country 
and are a primary consideration in selecting a geographical area in which to 
construct a new plant. 
Access to a "Research Community" 
Since a manufacturer's sales position in the industry to a large extent 
depends on the development of new products through research, the company 
would find it advantageous to have its operations located in or near a 
research community. The producer would thus have access to research personnel 
required for a product development program. 
Competition is pronounced among the producers in the research and 
development of new products. A manufacturer who attempts to produce an 
"unchanged" product in this industry would quickly experience a sharp drop 
in sales. Appendix 1 indicates the change in volume of sales of individual 
products. 
1/ Selling and advertising expenditures increased from 12.9 per cent of 
net sales in 1950 to 24.0 per cent in 1958. Research expenditures increased 
from 4.4 per cent in 1950 to 6.4 per cent in 1958. Ibid., and Administered  
Prices, hearings before the Subcoumdttee on Antitrust and Monopoly of the 
Cmumittee on the Judiciary, United States Senate, Eighty-Sixth Congress, 
Second Session, pursuant to S. Res. 57, U. S. Government Printing Office, 
Washington, D. C., 1960. 
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Centralization of the Industry 
Products in this industry in almost all instances have a high manufac-
turer's value per pound. Therefore, the cost of shipping drugs either in 
bulk or packaged form from the manufacturer to the buyer is negligible. Also, 
the production of antibiotics involves complicated chemical processes which 
in turn necessitate a high investment in plant and equipment. The production 
process must be carried out on a large scale to be economically feasible. 
Because of these conditions the firms in this industry have shown little 
tendency to decentralize their antibiotic operations. Each manufacturer 
sells to a national market. Figure 1 indicates the location of manufac-
turers of antibiotics. 
Antibiotics are generally distributed through wholesalers and retailers 
to the final consumers. They are never sold directly to the ultimate con-
sumer by the manufacturer. Appendix 3 indicates the various channels through 
which the items are marketed. 
Because of the fact that the ultimate consumer does not choose the par-
ticular antibiotic he uses, advertising and other promotional efforts of the 
manufacturers are directed toward physicians and veterinarians who prescribe 
the particular drug used by the consumers. 
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FIGURE 1 
LOCATION OF ANTIBIOTICS MANUFACTURING PLANTS 
THE NEED FOR NEW PLANTS 
Market Growth 
In just two years, between 1956 and 1958, the dollar volume of sales 
of antibiotics rose 27.6 per cent, to $431 million. Table 1 indicates that 
tonnage of antibiotics sales increased almost 170 per cent from 1951 through 
1960. This growth trend is expected to continue throughout the 1960's. 
Sales of all antibiotics should increase to $750 million annually by 1968. 
The rapid increase in sales will engender the need for new plants to 
meet the demand. Although there is at present no shortage of capacity, the 
75 per cent increase in sales forecast in six years will utilize present 
capacity and more. 
Location Factors  
A plant to make antibiotics requires a location with the following 
special characteristics (see Introduction): 
1. large supplies of cooling water, 
2. high capacity waste disposal facilities, 
3. large land areas, and 
4. availability of trained research personnel. 
If in addition, the company can find an area where cost savings can be 
obtained, such an area would be an excellent location -- especially if a 
volume market exists there as well. 
The cost of goods sold in the entire antibiotics manufacturing industry 
in 1958 averaged 32.3 per cent of net sales. Selling and advertising expen-
ditures accounted for 24.0 per cent of the sales, while research costs 
accounted for 6.4 per cent of the total. Net operating profit after taxes 
amounted to 13.1 per cent of net sales for the industry, while general and 
administrative expenses amounted to 11.2 per cent of sales. 
Although manufacturers' expenditures on research and sales promotion 
will undoubtedly have to remain as high or higher than the above figures in 
order to compete effectively, labor costs per unit output can be reduced 
when new plants are constructed, both by building more efficient plants and 
by locating the new facilities in geographical areas where wages represent 
a smaller percentage of the value of output. 
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Table 1 
Sales of Antibiotics by U. S. Manufacturers, 1951-1960 
(in thousands of pounds) 
For 
Human & Veterinary Use: 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 
Bacitracin - - 4 5 - - 6 6 6 5 
Dihydrostreptomycin 264 301 297 286 332 431 462 465 492 363 
Neomycin, base - 9 11 14 19 24 28 30 
Penicillin 120 147 144 113 112 137 133 134 160 196 
(Potassium) 
Penicillin 340 390 509 258 259 343 344 284 268 417 
(Procaine) 
Penicillin 27 51 55 56 74 113 124 73 61 64 
(All other) 
Streptomycin 36 41 104 75 99 147 169 166 240 329 
Tetracycline - - 186 299 243 257 256 
All other 268 391 354 461 480 366 430 487 530 668 
For 
Animal Feed Supplements, 
Food Preservation, and 
Crop Spraying: 
Total 196 172 391 562 553 683 795 1053 1108 1126 
Grand Total 1251 1493 1858 1825 1920 2420 2781 2935 3150 3454 
SOURCE: U. S. Tariff Commission, Synthetic Organic Chemicals, 
U. S. Government Printing Office 
Therefore, a location for an antibiotics plant is one which includes 
the four characteristics listed on page 5, has a low wage input per unit of 
product and offers a large market. 
ATLANTA AS A LOCATION 
Although drug manufacturers distribute world-wide from a single plant 
and the location of the market is therefore not critical in plant location, 
a big market near the plant is nevertheless, always an advantage. 
Market  
Metropolitan Atlanta is one of the largest market areas in the country 
for drugs; $233 million worth were sold wholesale in the city in 1958. The 
entire New England area in the same year wholesaled only $246.9 million, 
while the states of Florida, North Carolina, and South Carolina combined 
wholesaled only $234.9 million. Excluding Georgia, only eight states 
wholesale more drugs than metropolitan Atlanta alone. To put it another 
way, 41 states wholesale less drugs than Atlanta. Of all cities in the 
United States only New York, Chicago, and Los Angeles had higher sales. 
From these comparisons it is obvious that Atlanta represents a huge market 
for all drugs. The market for antibiotics in the area would be in proportion 
to the market for all drug products. 
In addition to itself being a huge, highly concentrated market, Atlanta 
can offer a manufacturer advantages in critical cost areas, as well as 
services comparable with those in the largest metropolitan areas. Probably 
the most significant of these advantages is that of substantially lower labor 
costs. Other advantages include a large source of adequate cooling water, 
waste disposal facilities, available land for plant sites, location near a 
major distribution point, and independent research capability in the area. 
Labor Savings  
Georgia production wage rates in the drug industry, as in many other 
industries, are significantly lower than the national average. The rate 
applicable to the manufacture of antibiotics is that for the Medicinals and 
Botanicals Drug Industry (SIC 2833). According to the 1958 Census of 
Manufactures, the average production wage rates in 1958.for selected regions 
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were as follows: 
New Jersey 	  $2.64 per hour 
New York 	  $2.58 per hour 
U. S. Average 	  $2.57 per hour 
Illinois 	  $2.45 per hour 
There are no published figures for Georgia, but based on similar job 
requirements, an estimate has been made of $2.00 to $2.13 per hour. In 
this report $2.13 has been used for calculations. 
Because of the above wage differential an Atlanta manufacturer with 
shipments amounting to $9 million in 1958 could have realized a savings of 
$156,352 in production labor costs over a similar operation in Illinois. 
This saving was computed by the following formula: 
Value of shipments per production man hour expended -- Illinois 
(SIC 2833) = $18.42 
Number of production man hours required for $9 million in shipments = 
$9,000,000  
- 488,599 man hours 
$18.42 
Labor savings of the Atlanta plant = 488,599 x ($2.45 - $2.13) = $156,352  
A New Jersey producer having the same yearly shipments would save 
$210,744 in production labor costs, while a New York producer would save 
$126,800 based on computations by the above formula. However, these cost 
reductions are based on wage differentials alone and do not include dif-
ferences in labor productivity between Atlanta and the above locations. They 
are based on the assumption that the same number of man hours would be 
required in the North as in the South for the same production. But there are 
many indications that such is not the case.-
1/ 
 





 from the 1958 Census of Manufactures based on 
the relationship of value of shipments in each locality to production wages 
paid in the same locality indicates the following total production labor sav-
ings (other things being equal) of an Atlanta plant over plants in the three 
states mentioned above: 
Labor savings of Atlanta plant over Illinois plant = $621,000 (51.9%) 
Labor savings of Atlanta plant over New Jersey plant = $513,000 (47.2%) 
Labor savings of Atlanta plant over New York plant = $153,000 (20.7%) 
Thus the combination of lower wage rates and increased productivity 
would provide a substantial cost advantage to an Atlanta producer. 
Water Supply  
The Chattahoochee River, which runs through the west section of Atlanta, 
(Figure 3) is the longest and one of the largest rivers in the state. It 
empties into the Apalachicola River at the southwest tip of Georgia. The 
average flow at Atlanta is 1.68 billion gallons per day and steadily increases 
downstream. ?/ Thus the Chattahoochee should provide more than ample water for 
an antibiotics plant. 
Water Temperature  
Since a very large portion of the water used by an antibiotics plant is 
used for cooling purposes during the production process, the temperature of 
the water used is of primary importance. Generally, it is desirable to have 
water not above 60 ° F. for cooling purposes. Table 2 indicates the average 
1961 monthly temperatures of the Chattahoochee River at three separate 
locations. 
1/ Appendix 2. 
2/ The lowest flows on record were 201.8 million gallons in Atlanta 
(Clayton Sewage Treatment Plant) and 298.7 million gallons at Whitesburg (25 
miles southwest of Atlanta). 
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FIGURE 2 
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Table 2 
Average Monthly Temperatures of Chattahoochee River Water, 1961 1/ 
Buford Dam 	 City of Atlanta 	 Whitesburg 
Area* 	 Intake Station ** Area *** 
(30 mi. N.E. 	of Atlanta) 	(In N.W. Atlanta) 	(25 mi. S.W. of Atlanta) 
January 49 0 F. 	 450 F. 460 F. 
February 50 	 48 50 
March 47 	 53 55 
April 48 	 56 57 
May 47 	 59 66 
June 48 	 64 73 
July 49 	 64 74 
August 50 	 63 75 
September 50 	 64 74 
October 50 	 58 65 
November 50 	 60 56 
December 50 	 50 51 
Source: * U. S. Army Corps of Engineers, Atlanta Office 
** City of Atlanta Water Works 
*** Georgia Power Company, Plant Yates 
It is evident that the temperature of this river water is sufficiently 
low for cooling purposes without refrigeration during most of the year. The 
water used during the hotter months would require a minimum of refrigeration 
before use. 
Waste Disposal  
The Chattahoochee River, according to a leading authority on water pol-
lution in Georgia, has a relatively low rate of pollution. It is this 
authority's opinion that the river at a point 10 miles or more southwest of 
Atlanta's city limits could easily handle the volume of antibiotics waste of 
most producers. However, since the content and volume of waste varies be-
tween individual companies, the need for any filtering ponds and equipment 
would have to be studied on a company basis. The Chattahoochee would be able 
1/ See Figure 2 for location of the three areas. 
1 1 
to handle a large volume of unfiltered waste, however, at a point southwest 
of Atlanta. 
Land Availability  
Land is available along the Chattahoochee River in sufficient quantity 
for antibiotics plants at relatively low cost. 
Raw Material  
A preliminary check of raw material sources in the Southeast for 
pencillin manufacture indicates that at least 30 per cent (by weight) of the 
material required is available in the southern states. At least 53 per cent 
of the raw materials required for the manufacture of dihydrostreptomycin is 
available in the same area. 
It is indicated that comparable percentages of materials required for 
the manufacture of other antibiotics are available in the same area. 
Transportation of Goods and People  
It has been pointed out that Atlanta is an excellent market. This is 
so not because Atlanta is such a big consumer, but because it is such an 
excellent distribution point. 
Atlanta is the major transportation center of the South. It has the 
service of 7 railroads, over 75 motor freight carriers, and 6 air freight 
carriers to deliver products to any point in the United States. The area 
has a higher volume of freight traffic than any other area in the South. 
Liaison with major cities is excellent. Flying time to Chicago is one 
and a half hours, and non-stop flights are available to most major cities in 
the U. S. At last count 53 cities could be reached non-stop from Atlanta, 
and another air line has been added since the count was made. 
Research  
Since Atlanta is a research and educational center, a manufacturer 
would be able to obtain either research or research personnel without diffi-
culty 
Atlanta's research activities range from food technology to nuclear 
physics. Business and industry find a wide variety of research facilities 
and specialists in commercial, institutional, and government laboratories 
in the Atlanta area. 
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In addition to the research facilities of private business and 
industrial firms, nine commercial laboratories in the Atlanta area perform 
contract research and provide consultation services and testing facilities. 
These cover such diverse fields as food bacteriology, insecticides, build-
ing materials, biophysics, animal nutrition, electronics, electrical 
engineering, physics, antenna measurement, textile and paper chemicals, and 
coumunication systems. 
Georgia Tech's Engineering Experiment Station does $4,000,000 worth of 
research annually, utilizing approximately 350 full time and an equal number 
of part time research personnel. 
Emory University, a private institution of national stature, working 
closely with the Communicable Disease Center (a division of the United States 
Public Health Service, headquartered in Atlanta) and with Grady Memorial 
Hospital, serves as a center of medical research activity. 
Oglethorpe University is well known for the cancer research conducted 
in its laboratories. 
In addition to the research capabilities the universities have to offer, 
they are a continuing source of graduates for industry. Over 3,800 students 
will receive graduate and undergraduate degrees in 1962 from Atlanta's 19 
colleges and universities. Moreover, the Communicable Disease Center trains 
approximately 6,000 technicians and specialists annually. 
Conclusion 
Atlanta is an excellent location for an antibiotics plant because it 
offers: 
1. large quantities of water for cooling and waste disposal, 
2. high production per dollar of wages paid, 
3. a concentration of research and educational activities, 
4. outstanding transportation facilities both for goods and 
for people, and 
5. a large market in the city itself. 
There will shortly be a need for industry expansion to supply the grow-




NATIONAL OUTPUT OF ANTIBIOTICS 1948-1956 
1948 1949 1950 1951 1952 1953 1954 1955 1956 
Product Use Pounds Pounds Pounds Pounds Pounds Pounds Pounds Pounds Pounds 
Penicillin M 155,873 247,053 402,179 599,361 638,138 726,687 906,250 643,301 886,249 
FS 4,155 28,039 31,259 40,094 47,316 81,666 173,455 
Streptomycin M 80,737 54,312 45,657 38,686 49,665 125,135 141,244 154,415 129,774 
FS 1,067 8,250 
AG 10,975 
Dihydrostreptomycin M 2,989 139,004 157,752 315,216 336,984 304,989 445,808 369,248 492,173 
Bacitracin M 26 2,071 3,150 3,313 4,578 5,750 6,717 3,956 2,518 
PS 49,364 10,743 1,241 2,941 6,121 21,104 
Chlortetracycline M 661 28,517 111,242 155,563 151,967 196,955 58,592 55,556 86,504 
FS 31,643 93,576 160,222 281,942 284,283 281,188 465,197 
AG 8,962 
Chloramphenicol M 46 12,608 71,570 91,771 136,676 4,892 14,151 53,365 85,408 
Tyrothricin M 75 55 44 884 159 619 1,093 
Oxytetracycline M 36,645 56,054 123,766 147,982 186,260 152,380 145,424 
PS 1,303 65,578 53,254 106,628 160,391 177,129 179,190 
Viomycin M 110 123 284 827 2,011 2,879 3,131 
Neomycin & salts M 1,495 8,161 13,102 24,747 27,721 16,896 
FS 29 
Polymyxin M 1 336 226 407 400 471 
Actidione M 90 452 952 655 
Erythromycin M 2,480 39,359 64,061 53,148 70,913 
Fumagillin M 355 170 146 
Carbomycln M 2,183 35 
Tetracycline M 39,753 270,235 257,065 220,074 
FS 820 
Nystatin M 3,399 15,623 22,085 
Anisomycin M 24 
Cycloserine Fl 637 14,198 
Amphomycin M 73 
Novobiocin M 19,410 
Oleandomycin M 17,815 
Candicidin M 2 
Total M 240,332 483,640 828,360 1,261,627 1,454,364 1,608,621 2,124,980 1,791,027 2,214,211 
Total FS 37,101 236,557 255,478 429,905 494,931 547,991 847,225 
Total AG 19,937 
GRAND TOTAL 240,332 483,640 865,461 1,498,184 1,709,842 2,038,526 2,619,911 2,339,018 3,081,373 
Source: Economic Report on Antibiotics Manufacture, 
Federal Trade Commission, 
U. S. Government Printing Office, June 1958. 
M - Medicinal Use 
FS - Feed Supplement 
AG - Agricultural Use 
14 
APPENDIX 2 
COMPARISON OF LABOR COSTS IN INDUSTRY 2833 
FOR $9 MILLION SHIPMENTS IN SELECTED AREAS OF U. S. 
(Based on Relationships of Wages Paid in Each Area 
to Value of Shipments in the Area in 1958) 
Formula: Production wages paid per dollar 






Labor Cost Reduction 
of Atlanta Plant 
(.133) 	x ($9,000,000) = $1,197,000 $576,000 $621,000 
New Jersey 
(.121) 	x ($9,000,000) = $1,089,000 $576,000 $513,000 
New York 
(.081) 	x ($9,000,000) = $729,000 $576,000 $153,000 
South (including Atlanta) 
(.064) 	x ($9,000,000) = $576,000 
1/ This ratio obtained from 1958 Census of Manufactures. 
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PRINCIPAL ANTIBIOTIC MARKET CHANNELS 
SOURCE: Economic Report on Antibiotics Manufacture, Federal Trade Commission, 
U. S. Government Printing Office, June 1958. 
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